Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity
Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France
Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Lung Cancer
To Advance Health Equity, Put Real-World Cancer Data to Work
Despite decades of scientific progress against cancer, access to treatment remains highly unequal. Some of the reasons — like institutional racism and poverty — are a reflection of our broader society. Other inequities may go unrecognized but are no less damaging. People with underlying health conditions, for example, may be excluded from clinical trials, preventing them from accessing leading-edge treatments and limiting the evidence available to guide their care.
With multiple drivers of
Read More
Johnson & Johnson Innovation Launches 3 Collaborations to Advance Healthcare in China
What You Should Know:
- Johnson & Johnson Innovation announces three strategic
collaborations with a focus on advancing healthcare solutions in China.
- The three strategic collaborations are focused on leveraging advances in science and technology to address areas of high unmet medical need across several areas, including discovery science, lung cancer, and medical devices
Johnson & Johnson Innovation, a division of Johnson & Johnson (China) Investment Limited, today
Read More
Innovative Technologies Are the Future of Respiratory Care and Treatment
Breath measuring algorithms, smart inhalers, and wearable analytics are at the forefront of respiratory care technology. Lung cancers, including mesothelioma and asthma, account for 70% of the country’s breathing issues. Technological advancements are making it easier for specialists to diagnose and patients to administer self-care.
As the COVID-19 pandemic rages forward, the advancement of pulmonary technology has gotten a boost. There is no way for the medical field to prepare for the
Read More
Philips Launches Advanced 3D Imaging Navigation Platform for Faster Lung Cancer Diagnosis
What You Should Know:
- Philips paves the way for faster lung cancer diagnosis and treatment with advanced 3D imaging and navigation platform with the launch of Azurion Lung Edition.
- By speeding diagnosis and treatment, Azurion Lung Edition
is helping to transform lung cancer care, contributing to dramatically improved
outcomes and reduced costs.
Royal Philips, today
announced the launch of Azurion
Lung Edition, an advanced 3D imaging and navigation platform to accelerate
the
Read More
Syapse Lands $30M to Accelerate Real-World Evidence in Oncology
What You Should Know:
- Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine.
- Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine.
Syapse, a San
Francisco, CA-based provider of precision oncology
solutions announced $30
Read More
Machine Learning Will Transform Medicine, but Only if We Use it Right
World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer.
It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event, the first sign that artificial intelligence could become equal to or even
Read More
Top 60 Health IT/Digital Health Mergers & Acquisitions in 2019
- From Google's acquisition of Fitbit to Philips acquisition of Carestream Health's health IT business, here is a look at some of the biggest health IT/digital health mergers & acquisitions in 2019 by each quarter.
Q1 M&A Activity
Johnson & Johnson Acquires Auris Health for $3.4B to Expand Digital Surgery Portfolio
Johnson & Johnson acquiresAuris Health, a developer of robotic technologies for $3.4 billion in cash. Auris Health is a privately-held developer of
Read More
McKesson, Aetion Partner on Real-World Evidence (RWE) in Cancer Research
- Aetion and McKesson announced a strategic collaboration focused on advancing the use of real-world evidence (RWE) in cancer research. - Relationship pairs Aetion Evidence Platform and McKesson’s robust oncology data sets to accelerate regulatory-grade oncology studiesAetion and McKesson, today announced a strategic collaboration focused on advancing the use of real-world evidence (RWE) in cancer research to benefit patients, regulators, the biopharma industry, and payers. The partnership will
Read More
AI vs. Humans: AI Solution Beats Stanford Radiologists in Chest X-ray Diagnostics Competition
JF Healthcare, a Nanchang, China-based medical diagnostic startup is the first organization in the world to beat Stanford University radiologists in a competition designed by the Stanford Machine Learning group to compare the capability of artificial intelligence (AI) to human experts in interpreting chest x-rays.Standard Chest X-ray Diagnostic Competition ResultsThe AI team from JF Healthcare recently achieved an average AUC score (a measure of diagnostic accuracy) of 0.926 and is currently
Read More
